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Abstract Hepatocyte nuclear factor-3Q (HNF-3Q) is an im-
portant regulator of liver-specific genes and the expression of this
factor is reduced in the liver injured by carbon tetrachloride
(CCl4). Wistar rats were infected with a recombinant adenovirus
carrying the cDNA for HNF-3Q (AxCAHNF3Q) via the tail vein
and were treated with CCl4 by intraperitoneal injection. Liver
damage, such as swelling of the hepatocytes and increases in
serum marker enzymes were markedly alleviated by Ax-
CAHNF3Q infection. Interestingly, hepatocyte growth factor
(HGF) was strongly induced in the AxCAHNF3Q-infected liver.
Likewise, HNF-1K and HNF-1L levels were increased, but HNF-
3K and HNF-3L levels were depressed in the liver. Our results
suggest that the transduced HNF-3Q gene leads to a hepatopro-
tective effect via the induction of HGF by the combined actions
of liver-enriched transcription factors.
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1. Introduction
The mammalian liver is the largest solid organ and plays a
central role in the metabolism of nutrients, waste matter and
poisonous chemicals, among other things, by producing pro-
teins and liver-speci¢c enzymes such as albumin, transthyre-
tin, aldolase, alcohol dehydrogenase and many other hepatic
enzymes. The expression of these proteins is controlled by the
combined actions of liver-enriched transcription factors such
as hepatocyte nuclear factor (HNF)-1K, 1L, HNF-3K, 3L, 3Q,
HNF-4 and C/EBPK, L, N [1].
Mature hepatocytes express at least three HNF-3 isoforms
(K, L and Q) that interact to regulate liver-speci¢c phenotypes
[1^3]. Since these di¡erent HNF-3 isoforms have overlapping
functions, the speci¢c physiological role of each isoform in
hepatocytes is not well understood. The targeted disruption
of the HNF-3Q gene decreases the expression of liver-speci¢c
genes, indicating that HNF-3Q is an important activator for
some hepatic genes in vivo [2]. In addition, the expression of
HNF-3Q, compared with that of HNF-3K and HNF-3L, may
be necessary for hepatocytes to maintain highly di¡erentiated
functions [4]. In our previous study, to identify the role of
HNF-3Q in the regulation of liver-speci¢c gene expression
and the maintenance of di¡erentiated liver functions, replica-
tion-defective adenovirus vectors were used to e⁄ciently over-
express the rat HNF-3Q gene in primary hepatocytes. As a
result, the transgene was shown to conserve some liver func-
tions in the hepatocytes [5].
Previously, endogenous HNF-3Q gene expression has been
revealed to be down-regulated in rats with carbon tetrachlo-
ride (CCl4)-induced hepatic injury, compared with the up-
regulated expression of HNF-3K and 3L. It is of interest to
de¢ne the involvement of HNF-3Q in the molecular patho-
physiology of acute liver damage. Since the damage by CCl4
occurs broadly in the liver, we analyzed the role of HNF-3Q
by means of adenovirus-mediated gene transfer, which
achieves e⁄cient overexpression in almost 100% of hepato-
cytes through the blood circulation from the portal vein, pe-
ripheral vein or abdominal cavity in the normal rat [6,7].
2. Materials and methods
2.1. Recombinant adenovirus carrying the rat HNF-3Q gene
The recombinant adenovirus harboring the rat HNF-3Q gene was
constructed as described previously [5,8]. Brie£y, cDNA encoding
HNF-3Q was inserted into the SwaI site of cosmid vector pAxCAwt,
carrying the cytomegalovirus immediate early enhancer and modi¢ed
chicken L-actin promoter (CAG promoter) [9] and rabbit L-globin
polyadenylation signal in a cassette. The construct was co-transfected
with EcoT221-digested Ad5-dlX DNA tagging viral terminal protein
into the 293 cells, which were a human embryonic kidney cell line
transformed by E1A and E1B genes. The recombinant adenovirus
(AxCAHNF3Q) was generated by genetic recombination and was
propagated within the 293 cells. Virion was puri¢ed by CsCl-equilib-
rium centrifugation and titrated with the 293 cells by a conventional
procedure [10]. A recombinant adenovirus vector AxCALacZ bearing
the Escherichia coli LacZ gene was provided by Dr Izumu Saito and
used as a control [10].
2.2. Animal treatments
Male adult Wistar rats weighing 150 g were purchased from the
Shizuoka Laboratory Animal Center Japan. Each three rats were in-
fected with 1.5U108, 5U108 and 1.5U109 plaque forming units (pfu)
of AxCAHNF3Q or 1.5U109 pfu of AxCALacZ via the tail vein.
Mock-infected control rats were intravenously given an equal volume
of saline. At 4 days post-infection, these rats were intraperitoneally
injected with 2 ml of CCl4 :olive oil (1:1 mixture) per kg of body
weight. All rats were fed ad libitum and received human care in
compliance with the institution’s guidelines for the care and use of
laboratory animals in research.
2.3. Histological procedures and biochemical measurements
Livers from the rats were ¢xed in 10% formaldehyde and embedded
in para⁄n. The para⁄n blocks were sectioned at 5 Wm and counter-
stained with hematoxylin and eosin. The liver-speci¢c cytosolic en-
zyme activities of alanine transaminase (ALT) and aspartate trans-
aminase (AST) in blood of the rats were determined according to
the manufacturer’s manual (Wako Pure Chemicals, Tokyo, Japan).
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2.4. RNA extraction and Northern blot analysis
Total RNA was extracted from the livers of rats infected with
adenovirus vectors as described elsewhere [11]. Total RNA (10 Wg)
was electrophoresed in a 7% formaldehyde agarose gel and transferred
to a nylon membrane. The membrane was hybridized with speci¢c
cDNA probes for 24 h at 42‡C in 50% formaldehyde with sodium
phosphate-EDTA solution. Probes were radiolabelled by the random
primer method. Intensities of the hybridization signals were deter-
mined by densitometric scanning of the autoradiograms and by a
Molecular Imager (Bio-Rad Laboratories, CA, USA).
3. Results
3.1. Transferred HNF-3Q alleviates acute hepatic injury
We have previously shown that adenovirus-transferred
HNF-3Q conserves some liver function in primary cultured
hepatocytes of the adult rat [5]. On the basis of these obser-
vations, it is of interest to determine whether HNF-3Q would
be of potential bene¢t in rats with CCl4-induced acute liver
injury. Hence, Wistar rats were infected with 100 Wl (1.5U109
pfu) of AxCAHNF3Q, or AxCALacZ as a control, via the tail
vein. At 4 days post-infection, liver damage was induced in
the infected rats by CCl4 and the rat livers were then analyzed
in terms of their biochemical and morphological features.
ALT and AST activity in the sera of mock- and AxCA-
LacZ-infected rats were increased 5^7-fold over that of the
controls in normal rats, whereas in the AxCAHNF3Q-infected
rats, there was an approximately 60% increase in the activity
of these enzymes (Fig. 1). These data show that the trans-
ferred HNF-3Q gene can alleviate hepatic injury induced by
CCl4.
A histological analysis was therefore carried out with the
livers from these rats. As shown in Fig. 2, numerous hepato-
cytes were found to exhibit severe centrilobular necrosis (in-
dicated by arrows) with the in¢ltration of leukocytes (indi-
cated by arrowheads) in mock- (Fig. 2B) and AxCALacZ-
infected (Fig. 2C) rat liver. In contrast to the livers of rats
infected with AxCAHNF3Q (Fig. 2D), the levels of injured
hepatocytes were markedly reduced, similar to the levels in
the normal liver (Fig. 2A). These ¢nding indicate that the
adenovirus-transferred HNF-3Q gene leads to hepatoprotec-
tive e¡ects against CCL4-induced acute hepatic injury.
3.2. Involvement of HNF-3Q in hepatocyte growth factor
(HGF) gene expression
The expression of HGF is rapidly and dramatically induced
by either partial hepatectomy or chemical agents, indicating
that HGF serves as a potent hepatotrophic factor for liver
regeneration [12,13]. As shown in Fig. 3, Northern blot anal-
Fig. 1. AST and ALT activities in the sera of treated rats. Sera
were obtained from the normal control and mock-, AxCALacZ
(1.5U109 pfu)- and AxCAHNF3Q (1.5U109 pfu)-injected and CCl4-
treated rats. AST and ALT activities are represented by an open
box and a hatched box, respectively. n = 3, the mean þ S.D. are
shown.
Fig. 2. Histological features of the CCl4-injured liver. Liver sections were prepared from (A) normal rat and (B) mock-, (C) AxCALacZ
(1.5U109 pfu)- and (D) AxCAHNF3Q (1.5U109 pfu)-infected rats, which were followed by CCl4 treatment for 2 days. These sections were
stained with hematoxylin-eosin and microphotographed at a magni¢cation of U30.
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ysis showed that the HGF levels were slightly increased in the
CCl4-treated livers of the mock- and AxCALacZ-infected rats
compared with those of normal rat livers. In contrast, a dra-
matic increase in HGF expression was observed in the rat
liver infected with AxCAHNF3Q (1.5U109 pfu). On the other
hand, expression of the c-met gene encoding the membrane
receptor for HGF was scarcely increased or even decreased by
CCl4 treatment and AxCAHNF3Q infection (Fig. 3). Taken
together with previous reports that HGF has a potent cyto-
protective or anti-hepatitis action [14,15], these results support
the hypothesis that HGF is activated by HNF-3Q and that
HGF overexpression is responsible for the hepatoprotective
e¡ects against CCl4-induced injury.
3.3. HNF-3Q controlled expression of liver-enriched
transcription factors
The liver regenerates completely when moderate damage is
in£icted by partial hepatectomy or chemical agents and the
expression of liver-enriched transcription factors is also con-
comitant with this compensatory hepatocyte proliferation
[16,17]. Fig. 4 shows the results of the Northern blot analysis,
which indicate that endogenous HNF-3Q mRNA (indicated
with an arrow) was decreased 50% in the CCl4-injured liver
compared with the normal rat. However, the transduced
HNF-3Q mRNA (indicated with an arrowhead) was increased
dose-dependently by the AxCAHNF3Q infection in spite of
CCl4 treatment. HNF-3K and HNF-3L were up-regulated in
the CCl4-treated livers of mock- and AxCALacZ-infected rats.
Conversely, These mRNAs in the AxCAHNF3Q-infected liver
were not observed to be induced by CCl4 treatment.
Moreover, HNF-1K and 1L mRNAs were little in£uenced
by CCl4 treatment, while these mRNAs were strongly induced
in the HNF-3Q-transduced liver (1.5U109 pfu of the Ax-
CAHNF3Q). The expression of C/EBPK in rat livers with
acute liver injury was decreased by approximately 50% com-
pared to that in mock- and AxCALacZ-infected rats. Further-
more, the mRNA levels of C/EBPL were slightly increased by
CCl4-induced liver injury, independently of AxCAHNF3Q in-
fection. On the other hand, the expression of HNF-4 was
merely in£uenced by CCl4 treatment or AxCAHNF3Q infec-
tion. These results suggest that the expression patterns of
liver-enriched transcription factors are re£ected by the levels
of HNF-3Q overexpression. Notably, the up-regulation of
both HNF-1K and HNF-1L is related to the alleviation of
CCl4-induced acute hepatitis.
4. Discussion
In our previous study, the endogenous HNF-3Q gene, as
well as other hepatic genes, was extremely down-regulated
in the CCl4-treated liver. Furthermore, in this study, the ad-
enovirus-transferred HNF-3Q gene was demonstrated to lead
to hepatoprotective e¡ects against CCl4-induced acute hepatic
injury.
Signi¢cantly, our results show that HGF is remarkably ac-
Fig. 3. E¡ects of HNF-3Q gene transfer on the expression of HGF
and c-met. (A) Northern blot analysis probed HGF and c-met are
shown by a typical pattern. Lane 1, liver RNA from the normal
rat; lane 2, liver RNA form the rat injected with saline, followed by
CCl4 treatment; lane 3, liver RNA form the rat infected with Ax-
CALacZ and treated with CCl4 ; lanes 4^6, liver RNAs form the
rats infected with AxCAHNF3Q (1.5U108, 5U108, 1.5U109 pfu/rat,
respectively) and treated with CCl4. (B) The hybridization signals
were quanti¢ed by a Molecular Imager and normalized to those of
18S rRNA. Relative gene expression is shown by the ratio to the
levels in normal liver. n = 3, the mean with S.D. are shown.
Fig. 4. Expression of liver-enriched transcription factors. Northern
blot analyses were performed using 32P-labelled cDNA as probes,
shown on the left of the panels. Lanes are the same that in Fig. 3.
HNF-3Q mRNA derived from the endogenous gene is indicated by
an arrow and that from the transduced gene is shown by an arrow-
head.
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tivated by HNF-3Q derived from a high titer of AxCAHNF3Q.
Previous studies show that following the onset of various
types of hepatic injuries, HGF mRNA expression is rapidly
up-regulated in the livers of experimental animals [12,13]. In
addition, serum HGF levels are elevated in patients with var-
ious hepatic disorders [18]. Extensive studies have revealed
that HGF strongly stimulates the DNA synthesis of hepato-
cytes in livers injured by partial hepatectomy or by CCl4 ad-
ministration [19]. Likewise, HGF has protective and therapeu-
tic e¡ects on experimental liver ¢brosis/cirrhosis caused by
chemical compounds, immunological responses or metabolic
disorders, indicating that the e⁄cacy of HGF does not seem
to be related to the degradation of hepatotoxins, but that it
induces potent cytoprotective or anti-hepatitis actions [14].
These observations suggest that HGF activated by the over-
expression of HNF-3Q may be responsible for the hepatopro-
tective e¡ects described in this study. However, the binding
site for the HNF-3Q transcription factor has not been located
in the 5P-£anking region of the rat HGF gene, as far as the
sequence has been analyzed [20]. Therefore, based on the re-
sults of this study, we cannot explain the direct or indirect
interaction between the transcriptional regulation of HNF-3Q
and HGF expression.
The mammalian liver undergoes complete regeneration
after damage from partial hepatectomy or chemical agents
via proliferation of the remaining liver [21]. This compensa-
tory hepatocyte proliferation induces the expression of some
liver-enriched transcription factors as well as many of the
immediate early genes such as c-jun, c-fos and c-myc [22]. D-
galactosamine-induced liver injury activates C/EBPN, HNF-
3K, L, Q and ¢nally C/EBPL in proliferating liver epithelial
cells [23]. Oval cells, which are induced by the administration
of 2-acetylamino£uorene and partial hepatectomy, express
HNF-1K, L, HNF-3Q and C/EBP [17,24]. Further study is
needed to elucidate why HGF is activated by HNF-3Q over-
expression in the CCl4-injured liver.
In conclusion, the hepatoprotective e¡ects of HNF-3Q
overexpression may result from the up-regulation of HGF
through the combined actions of liver-enriched transcription
factors.
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